N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic Solution for Precision Oncology

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc., provider of Diagnostic Strategy Roadmaps™ and Treatment Strategy Roadmaps™ for personalized cancer care, announced today that the company has entered into a strategic collaboration with Foundation Medicine, Inc. to support the development of its fully informative molecular cancer profiles that can be used to guide individualized patient treatment strategies.

MORE ON THIS TOPIC